Investing

BridgeBio Pharma : BBIO

BBIO

Stock Data

$65.48

$1.60 (2.50%)

Asset Type

Common Stock

Exchange

NASDAQ

Currency

USD

Country

USA

Sector

HEALTHCARE

Industry

BIOTECHNOLOGY

BridgeBio Pharma Inc is a pioneering biopharmaceutical company focused on developing innovative medicines for genetic diseases and cancers. With a robust pipeline, it is advancing treatments through clinical trials, including therapies for TTR amyloidosis, achondroplasia, congenital adrenal hyperplasia, autosomal dominant hypocalcemia, and limb-girdle muscular dystrophy. Founded in 2015 and based in Palo Alto, California, BridgeBio collaborates with leading institutions to transform scientific discoveries into breakthrough treatments.

All BridgeBio Pharma Articles

7 Articles

Lee Jackson | 13 hours ago

Here Are Wednesday’s Top Wall Street Analyst Research Calls: Boyd Gaming, Chipotle Mexican Grill, Conagra, Dollar General, MGM Resorts International, Omnicom Group, Yum! Brands, and More

Mid-Day Stocks: Stocks are trading lower on Wednesday, as oil and yields move higher. Once again, it was “Welcome back,…

David Moadel | May 19, 2026 at 12:15 PM EDT

Citi Initiates BridgeBio at Neutral: Why the Cardiomyopathy Story Isn’t a Slam Dunk

BridgeBio Pharma (NASDAQ:BBIO | BBIO Price Prediction) received a Neutral initiation from Citi Neutral on Tuesday, reflecting a measured stance…

Lee Jackson | Dec 11, 2025 at 8:17 AM EST

Here Are Thursday’s Top Wall Street Analyst Research Calls: American Eagle Outfitters, Ferrari, Intuitive Surgical, Roku, PayPal, Synopsis, Visa, and More

Pre-Market Stock Futures: Futures are trading lower after a big rate-cut rally on Wednesday was sideswiped by Oracle’s disappointing earnings…

Rich Duprey | Aug 14, 2025 at 10:52 AM EDT

2 High-Yield REIT Picks to Capitalize on Imminent Fed Rate Cuts

The latest Consumer Price Index (CPI) report has sparked optimism, revealing consumer prices rose 0.2% in July, meaning the index…

Rich Duprey | Aug 11, 2025 at 9:56 AM EDT

Is This Ultra-High Yield Dividend Stock a Steal at a 19% Discount?

A Fallen Giant Pfizer (NYSE:PFE | PFE Price Prediction) has been a bitter pill for investors to swallow. Down 19%…

Lee Jackson | Jun 15, 2022 at 8:57 AM EDT

Wednesday’s Top Analyst Upgrades and Downgrades: Chesapeake Energy, eBay, Hewlett Packard Enterprise, Oracle, Phillips 66, US Steel and More

Wednesday's top analyst upgrades and downgrades included Accenture, Bridgebio Pharma, Chesapeake Energy, eBay, Hewlett Packard Enterprise, Huntsman, New York Community…

Lee Jackson | Dec 29, 2021 at 8:52 AM EST

Wednesday’s Top Analyst Upgrades and Downgrades: Adobe, Ciena, Hilton, Paysafe, Riot Blockchain, Shopify, Tesla and More

Wednesday’s top analyst upgrades and downgrades included Adobe, Akamai Technologies, BridgeBio Pharma, Ciena, Eqonex, Hilton Worldwide, Paysafe, Riot Blockchain, Shopify,…